The mission of the Knowledge Transfer Unit (KTU) at ICMAB is to translate the ICMAB research into social use via technology and knowledge transfer, through a process which provides social and economic benefits to the ICMAB, the Industry and the society.
We are approaching a quality improvement of our technology transfer processes, especially for new marketing opportunities of our research results. For this reason, in 2018 we have completed the project "Review of technology transfer practices at ICMAB: assessing the technology transfer potentials along selected value chains" commissioned by the Fraunhofer- IMW.
Following the KTU improvement plan, we have increased our Human Resources by incorporating one new expert with strategic capabilities, especially in IP issues.
To date we have filed and licensed a significant number of patents, and we are responsible of advising our researchers in IPR related matters.
The Knowledge Transfer Unit is formed in 2018 by Susana Garelik and Alfonso del Rey.
The ICMAB has signed many contracts and collaborations with different types of companies, and, in addition, our researchers contribute by developing new knowledge in collaboration with our industrial partners in many European projects:
Industrial stakeholders recognised as key factors in driving innovation, knowledge transfer and competitiveness. They develop research and innovation agendas and roadmaps for action at EU and national level to be supported by both private and public funding. By working effectively together, they also help deliver solutions to major challenges of key concern to citizens such as the ageing society, the environment and food and energy security.
ICMAB participates in the following Technology Platforms:
National Technology Platforms:
European Technology Platforms:
Advanced Materials Cluster (Clúster MAV)
Association with the aim of promoting and contributing to the competitiveness of industries and institutions in the Advanced Materials field in Catalunya. It is formed by 35 industries and institutions.
In 2018, the ICMAB has applied for 6 patents:
Some of our patents are in co-ownership with companies:
And we have licensed the following patent:
NANOMOL Technologies S.L., born in UAB Research Park by the end of 2010, co-founded by researchers of NANOMOL research group of ICMAB and CIBER-BBN is a science and innovation driven company providing cutting edge solutions to process, structure and characterize, at micro and nanoscale, active molecules of pharma, biotech and cosmetic companies. Their mission is to generate revolutionary nanomedicines and drug delivery systems with outstanding therapeutic efficacy and patient’s compliance.